Aarotax Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.99 M
- Satisfied Charges ₹ 1.50 M
- Revenue Growth 17.63%
- Profit Growth -59.42%
- Ebitda 12.98%
- Net Worth 39.37%
- Total Assets 1.74%
About Aarotax Pharmaceuticals
Aarotax Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 October 2018 (Six years and three months 17 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹8.99 M. The company has closed loans amounting to ₹1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Preeti Srivastav and Ajit Srivastava serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999GJ2018PTC104772
-
Company No.
104772
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Oct 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Aarotax Pharmaceuticals Private Limited offer?
Aarotax Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Antiseptic Mouthwashes, Pharma & Bioanalytical Services, PCD Pharma Franchise.
Who are the key members and board of directors at Aarotax Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Preeti Srivastav
|
Director | 29-Jun-2024 | Current |
|
Ajit Srivastava
|
Director | 16-Oct-2018 | Current |
Financial Performance of Aarotax Pharmaceuticals.
Aarotax Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 17.63% increase. The company also saw a substantial fall in profitability, with a 59.42% decrease in profit. The company's net worth Soared by an impressive increase of 39.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aarotax Pharmaceuticals?
Unlock access to Aarotax Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Tisenta Medicare India LlpAjit Srivastava is a mutual person
Charges (Loans)
₹8.99 M
₹1.50 M
Charges Breakdown by Lending Institutions
- Idbi Bank Limited : 0.75 Cr
- Hdfc Bank Limited : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Oct 2024 | Hdfc Bank Limited | ₹1.49 M | Open |
| 10 Jun 2020 | Idbi Bank Limited | ₹7.50 M | Open |
| 23 Oct 2019 | Others | ₹1.50 M | Satisfied |
How Many Employees Work at Aarotax Pharmaceuticals?
Unlock and access historical data on people associated with Aarotax Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aarotax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aarotax Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
